Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Troponin Elevation in Consecutive Patients With Hip Fracture

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marjatta Strandberg, Turku University Hospital
ClinicalTrials.gov Identifier:
NCT01015105
First received: November 17, 2009
Last updated: November 4, 2016
Last verified: November 2016
  Purpose

The aims of this study is to study the occurrence of the troponin elevations, ECG changes, and cardiac symptoms in unselected consecutive patients with hip fracture.

Followup will be carried out up to one year period.


Condition Intervention
Hip Fracture
Other: observation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Troponin Elevation in Consecutive Patients With Hip Fracture

Resource links provided by NLM:


Further study details as provided by Turku University Hospital:

Enrollment: 200
Study Start Date: February 2009
Study Completion Date: January 2016
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients with hip fracture Other: observation
observation

  Eligibility

Ages Eligible for Study:   18 Years to 110 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
200 patients with hip fracture
Criteria

Inclusion Criterion:

  • Hip fracture diagnosed in Turku Univeristy Hospital between October 2009 and May 2010

Exclusion Criterion:

  • Patient refusal
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01015105

Locations
Finland
Turku University Hospital
Turku, Finland
Sponsors and Collaborators
Turku University Hospital
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Marjatta Strandberg, MD, Turku University Hospital
ClinicalTrials.gov Identifier: NCT01015105     History of Changes
Other Study ID Numbers: TnT in Hip Fracture 
Study First Received: November 17, 2009
Last Updated: November 4, 2016
Health Authority: Finland: Ethics Committee

Keywords provided by Turku University Hospital:
patients with hip fracture

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries

ClinicalTrials.gov processed this record on December 07, 2016